MsFLASH-02: Interventions for Relief of Menopausal Symptoms: A 3-by-2 Factorial Design Examining Yoga, Exercise, and Omega-3 Supplementation
NCT01178892 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 355
Last updated 2014-08-22
Summary
This study is the second clinical trial to be conducted by the Menopause Strategies - Finding Lasting Answers for Symptoms and Health (MsFLASH) research network, a group of investigators conducting clinical trials designed to find new ways to alleviate the most common, bothersome symptoms of the menopausal transition.
In this twelve-week clinical trial, 374 women aged 40-62 who are in the late menopausal transition or postmenopausal and experiencing bothersome hot flashes will be randomized to one of three behavioral intervention groups: yoga, exercise, or usual activity. All women will simultaneously be randomized to receive omega-3 supplementation or a matching placebo.
The primary aims of this trial are to compare the magnitude of changes in perceived, self-reported frequency and bother of vasomotor symptoms (VMS) before and after the intervention between yoga and the usual activity comparison group, between exercise and the usual activity comparison group, and between omega-3 fatty acid supplementation or placebo. The hypotheses to be tested are:
1. Women assigned to yoga will report lower frequency and less VMS bother than women assigned to the usual activity group at the end of a 12-week study period.
2. Women assigned to aerobic exercise at moderate-vigorous intensity will report lower frequency and less VMS bother than women assigned to the usual activity group at the end of a 12-week study period.
3. Women assigned to omega-3 fatty acid supplementation will report lower frequency and less VMS bother than women assigned to the placebo group at the end of a 12-week study period.
The omega-3 component of the study is double-blinded. For yoga, exercise, and usual activity, the outcomes assessors are blinded to the randomization assignments.
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
Placebo
Three placebo gel capsules filled with vegetable oil are taken daily for a total of approximately 2 grams of vegetable oil. Each gel capsule also contains 15 IU of vitamin E, natural lemon flavoring, rosemary extract, and a small amount of non-omega-3 fish oil.
- DIETARY_SUPPLEMENT
-
Omega-3
The study supplement, omega-3-fish oils, is taken as 3 gel capsules daily that together contain approximately 2 grams of fish oil. Each gel capsule (1/3 of the daily dose) has a total omega-3 dosage of 615 mg with two major omega-3 components of ethyl eicosapentaenoic acid (EPA; 425 mg) and docosahexaenoic acid (DHA; 100 mg). Vitamin E (15 IU), an antioxidant, is added to each gel capsule to prevent oxidation and preserve freshness. Each gel capsule also contains natural lemon oil and rosemary extract to enhance taste and freshness.
- BEHAVIORAL
-
Yoga
Yoga instruction is provided during 12 weekly 90-minute classes, designed for women without prior yoga experience. Each class includes an introductory breathing exercise, 11 to 13 gentle postures followed by deep relaxation with a visualization exercise. Study participants are expected to attend each of the 12 weekly yoga classes plus do daily 20-minute at-home practices. Classes are offered at 2 different times during the week.
- BEHAVIORAL
-
Exercise
The exercise intervention is facility-based aerobic exercise training on a treadmill, stationary bicycle or elliptical trainer performed 3 times a week for 12 weeks. The duration of each training session is determined for each woman based on the weekly total energy expenditure goal and workload required to achieve her prescribed exercise heart rate. Women train at 50-60% heart rate reserve (HRR) for the first month and then increase intensity to 60-70% HRR. To ensure that women train at their prescribed exercise heart rates, women wear Polar Heart Rate Monitors while exercising. The exercise counselor overseeing each exercise session records each participant's exercise heart rate every 5-10 minutes to document that she is in her target heart rate range.
- BEHAVIORAL
-
Usual Activity
Women randomly assigned to the "Usual Activity" group will be asked to continue with their usual physical activities during the study and not make changes. At completion of the intervention, women will have the opportunity to attend a yoga class and receive the yoga booklet, CD, and DVD for home use; or receive a one-month gym membership.
Sponsors & Collaborators
-
National Institute on Aging (NIA)
collaborator NIH -
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
collaborator NIH -
National Center for Complementary and Integrative Health (NCCIH)
collaborator NIH -
Office of Research on Women's Health (ORWH)
collaborator NIH -
Nordic Naturals
collaborator INDUSTRY -
Fred Hutchinson Cancer Center
lead OTHER
Principal Investigators
-
Andrea Z. LaCroix, PhD · Fred Hutchinson Cancer Center
-
Garnet Anderson, PhD · Fred Hutchinson Cancer Center
-
Susan D Reed, MD, MPH · University of Washington/Group Health Research Institute
-
Katherine M Newton, PhD · Group Health Research Institute
-
Bette Caan, DrPH · Kaiser Permanente
-
Barbara Sternfeld, PhD · Kaiser Permanente
-
Janet Carpenter, PhD, RN, FAAN · Indiana University School of Medicine
-
Hadine Joffee, MD, MSc · Massachusetts General Hospital
-
Lee Cohen, MD · Massachusetts General Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- FACTORIAL
Eligibility
- Min Age
- 40 Years
- Max Age
- 62 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-11-30
- Primary Completion
- 2012-05-31
- Completion
- 2012-05-31
Countries
- United States
Study Locations
More Related Trials
-
Clinical Trial Assessing Toxicity and Efficacy of MF101 for Hot Flashes
NCT00119665 ·Status: COMPLETED ·Phase: PHASE2
-
A Comparison of Farabloc Fabric With Placebo on Alleviation Hot Flash in Menopausal Women
NCT02006238 ·Status: UNKNOWN ·Phase: NA
-
MsFLASH-01: Escitalopram for Menopausal Symptoms in Midlife Women
NCT00894543 ·Status: COMPLETED ·Phase: NA
-
JDS-HF3.0 Supplementation on Menopause Related Quality of Life Outcomes in Postmenopausal Women
NCT07238478 ·Status: RECRUITING ·Phase: NA
-
PhytoSERM for Menopausal Hot Flashes and Sustained Brain Health
NCT06186531 ·Status: RECRUITING ·Phase: PHASE2
-
Skin Conduction Device and Patient Diary for Measuring Hot Flashes in Postmenopausal Women With Hot Flashes
NCT00427531 ·Status: COMPLETED ·Phase: NA
-
A Study of MK-6913 for the Treatment of Hot Flashes in Postmenopausal Women (6913-004)
NCT01015677 ·Status: TERMINATED ·Phase: PHASE2
-
One Week Clinical Study in Subjects With Menopausal Symptoms
NCT06794021 ·Status: COMPLETED ·Phase: NA
-
Hot Flash and Night Sweat Virtual Study
NCT06289907 ·Status: UNKNOWN ·Phase: NA
-
Stellate Ganglion Nerve Block in Treating Women With Hot Flashes
NCT00879164 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Hypnosis For Hot Flashes Among Postmenopausal Women in a Randomized Clinical Trial
NCT01293695 ·Status: COMPLETED ·Phase: NA
-
Effects of Estrogen and Hot Flashes on Mood in Postmenopausal Women
NCT01126801 ·Status: TERMINATED ·Phase: PHASE2
-
4-week Seaweed Supplementation on Menopause Symptoms and Psychological Wellbeing
NCT05759936 ·Status: COMPLETED ·Phase: NA
-
A Real-world Clinical Study on the Treatment of Menopausal Syndrome With Liuwei Dihuang Pills
NCT06874738 ·Status: NOT_YET_RECRUITING
-
The Effects of a Novel Probiotic Supplement on Menopausal Symptoms and Bone Health
NCT04001088 ·Status: COMPLETED ·Phase: PHASE2
-
Skin Conduction Device for Measuring Hot Flashes in Postmenopausal Women With Hot Flashes
NCT00427622 ·Status: COMPLETED ·Phase: NA
-
Effects of a Kappa Agonist on Hot Flashes in Menopausal Women
NCT02070718 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Exercise and Phytoestrogen on Bone, Metabolic Syndrome Criteria and Complaints of the Early Menopause
NCT00663104 ·Status: TERMINATED ·Phase: PHASE3
-
Symptom Monitoring and Menopausal Symptoms
NCT05603234 ·Status: COMPLETED ·Phase: NA
-
A Study of NOE-115 in Women With Vasomotor Symptoms Due to Menopause
NCT06385795 ·Status: COMPLETED ·Phase: PHASE2
-
S9626: Megestrol in Treating Hot Flashes Following Treatment for Breast Cancer
NCT00005975 ·Status: COMPLETED ·Phase: PHASE3
-
Randomized Placebo Controlled Clinical Study of an Oral Product in Subjects With Menopausal Symptoms
NCT06787443 ·Status: COMPLETED ·Phase: NA
-
The Effectiveness of a Proprietary Ashwagandha Extract on Menopausal Symptoms: A Three-Arm Randomized, Double-Blinded, Placebo Controlled Clinical Trial
NCT07210229 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study To Investigate The Effect Of A Natural Dietary Supplement On Peri-Menopausal Symptoms
NCT02497560 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweats
NCT06049797 ·Status: ACTIVE_NOT_RECRUITING